229 related articles for article (PubMed ID: 27241955)
1. Death from liver disease in a cohort of injecting opioid users in a Swedish city in relation to registration for opioid substitution therapy.
Jerkeman A; Håkansson A; Rylance R; Wagner P; Alanko Blomé M; Björkman P
Drug Alcohol Rev; 2017 May; 36(3):424-431. PubMed ID: 27241955
[TBL] [Abstract][Full Text] [Related]
2. The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study.
Degenhardt L; Larney S; Kimber J; Gisev N; Farrell M; Dobbins T; Weatherburn DJ; Gibson A; Mattick R; Butler T; Burns L
Addiction; 2014 Aug; 109(8):1306-17. PubMed ID: 24612249
[TBL] [Abstract][Full Text] [Related]
3. Is opioid substitution treatment beneficial if injecting behaviour continues?
Gjersing L; Bretteville-Jensen AL
Drug Alcohol Depend; 2013 Nov; 133(1):121-6. PubMed ID: 23773951
[TBL] [Abstract][Full Text] [Related]
4. Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England.
Marsden J; Stillwell G; Jones H; Cooper A; Eastwood B; Farrell M; Lowden T; Maddalena N; Metcalfe C; Shaw J; Hickman M
Addiction; 2017 Aug; 112(8):1408-1418. PubMed ID: 28160345
[TBL] [Abstract][Full Text] [Related]
5. Treatment for chronic hepatitis C in a cohort of opiate substitution therapy recipients in three Swedish cities - completion rates and efficacy.
Jerkeman A; Norkrans G; Lidman C; Westin J; Lagging M; Frimand J; Simonsberg C; Kakko J; Widell A; Björkman P
Eur J Gastroenterol Hepatol; 2014 May; 26(5):523-31. PubMed ID: 24637496
[TBL] [Abstract][Full Text] [Related]
6. Chronic hepatitis C in Swedish subjects receiving opiate substitution therapy--factors associated with advanced fibrosis.
Jerkeman A; Westin J; Lagging M; Norkrans G; Lidman C; Frimand J; Simonsberg C; Kakko J; Widell A; Björkman P
Scand J Infect Dis; 2014 May; 46(5):340-7. PubMed ID: 24552582
[TBL] [Abstract][Full Text] [Related]
7. The contributions of viral hepatitis and alcohol to liver-related deaths in opioid-dependent people.
Larney S; Randall D; Gibson A; Degenhardt L
Drug Alcohol Depend; 2013 Aug; 131(3):252-7. PubMed ID: 23237980
[TBL] [Abstract][Full Text] [Related]
8. Patterns of substance use and mortality risk in a cohort of 'hard-to-reach' polysubstance users.
Gjersing L; Bretteville-Jensen AL
Addiction; 2018 Apr; 113(4):729-739. PubMed ID: 28987019
[TBL] [Abstract][Full Text] [Related]
9. Causes of death in a cohort treated for opioid dependence between 1985 and 2005.
Degenhardt L; Larney S; Randall D; Burns L; Hall W
Addiction; 2014 Jan; 109(1):90-9. PubMed ID: 23961881
[TBL] [Abstract][Full Text] [Related]
10. The Effects of Opioid Substitution Treatment and Highly Active Antiretroviral Therapy on the Cause-Specific Risk of Mortality Among HIV-Positive People Who Inject Drugs.
Nosyk B; Min JE; Evans E; Li L; Liu L; Lima VD; Wood E; Montaner JS
Clin Infect Dis; 2015 Oct; 61(7):1157-65. PubMed ID: 26113656
[TBL] [Abstract][Full Text] [Related]
11. Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings.
Vickerman P; Martin N; Turner K; Hickman M
Addiction; 2012 Nov; 107(11):1984-95. PubMed ID: 22564041
[TBL] [Abstract][Full Text] [Related]
12. Estimation of life expectancy and the expected years of life lost among heroin users in the era of opioid substitution treatment (OST) in Taiwan.
Chang KC; Lu TH; Lee KY; Hwang JS; Cheng CM; Wang JD
Drug Alcohol Depend; 2015 Aug; 153():152-8. PubMed ID: 26054944
[TBL] [Abstract][Full Text] [Related]
13. Differences in polysubstance use patterns and drug-related outcomes between people who inject drugs receiving and not receiving opioid substitution therapies.
Betts KS; Chan G; McIlwraith F; Dietze P; Whittaker E; Burns L; Alati R
Addiction; 2016 Jul; 111(7):1214-23. PubMed ID: 26857811
[TBL] [Abstract][Full Text] [Related]
14. A cost-effectiveness analysis of opioid substitution therapy upon prison release in reducing mortality among people with a history of opioid dependence.
Gisev N; Shanahan M; Weatherburn DJ; Mattick RP; Larney S; Burns L; Degenhardt L
Addiction; 2015 Dec; 110(12):1975-84. PubMed ID: 26212260
[TBL] [Abstract][Full Text] [Related]
15. The increasing mortality burden of liver disease among opioid-dependent people: cohort study.
Gibson A; Randall D; Degenhardt L
Addiction; 2011 Dec; 106(12):2186-92. PubMed ID: 21749525
[TBL] [Abstract][Full Text] [Related]
16. The impact of blood-borne viruses on cause-specific mortality among opioid dependent people: An Australian population-based cohort study.
Vajdic CM; Marashi Pour S; Olivier J; Swart A; O'Connell DL; Falster MO; Meagher NS; Mao L; Grulich AE; Randall DA; Amin J; Burns L; Degenhardt L
Drug Alcohol Depend; 2015 Jul; 152():264-71. PubMed ID: 25936861
[TBL] [Abstract][Full Text] [Related]
17. Mortality and causes of death among people who inject amphetamine: A long-term follow-up cohort study from a needle exchange program in Sweden.
Åhman A; Jerkeman A; Blomé MA; Björkman P; Håkansson A
Drug Alcohol Depend; 2018 Jul; 188():274-280. PubMed ID: 29803034
[TBL] [Abstract][Full Text] [Related]
18. Test uptake and hepatitis C prevalence in 5483 Danish people in drug use treatment from 1996 to 2015: a registry-based cohort study.
Øvrehus A; Nielsen S; Hansen JF; Holm DK; Christensen P
Addiction; 2019 Mar; 114(3):494-503. PubMed ID: 30347471
[TBL] [Abstract][Full Text] [Related]
19. Mortality of treatment-seeking men and women with alcohol, opioid or other substance use disorders - A register-based follow-up study.
Pitkänen T; Kaskela T; Levola J
Addict Behav; 2020 Jun; 105():106330. PubMed ID: 32088539
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal analysis of change in individual-level needle and syringe coverage amongst a cohort of people who inject drugs in Melbourne, Australia.
O'Keefe D; Scott N; Aitken C; Dietze P
Drug Alcohol Depend; 2017 Jul; 176():7-13. PubMed ID: 28463684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
